Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

OVERLAP
34%
OVERLAP
BY WEIGHT
23
# OF OVERLAPPING
HOLDINGS
IBB
249
HOLDINGS
11%
ALSO IN PBE
PBE
28
HOLDINGS
82%
ALSO IN IBB
SECTOR DRIFT (IBB minus PBE)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in IBB |
Weight in PBE |
Overlap | |
---|---|---|---|---|
VERTEX PHARMACEUTICALS INC | 7.7% | 4.9% | 4.9% | |
AMGEN INC | 7.5% | 4.8% | 4.8% | |
REGENERON PHARMACEUTICALS | 5.5% | 4.8% | 4.8% | |
GILEAD SCIENCES INC | 7.8% | 4.6% | 4.6% | |
BIOGEN IDEC INC | 2.0% | 5.5% | 2.0% |
IBB Overweight Relative to PBE
ALNYLAM PHARMACEUTICALS INC | 5.7% | |
ARGENX SE ADR | 3.4% | |
GILEAD SCIENCES INC | 3.2% | |
IQVIA HOLDINGS INC | 3.2% | |
INSMED INC | 3.2% | |
VERTEX PHARMACEUTICALS INC | 2.8% | |
AMGEN INC | 2.7% | |
METTLER-TOLEDO INTERNATIONAL | 2.6% | |
NATERA INC | 2.2% | |
WATERS CORP | 1.9% |
IBB Underweight Relative to PBE
ROYALTY PHARMA PLC CLASS A | -4.7% | |
BIOGEN IDEC INC | -3.5% | |
ILLUMINA INC | -3.5% | |
INCYTE CORP | -3.3% | |
EXACT SCIENCES CORP | -3.1% | |
IONIS PHARMACEUTICALS, INC. | -3.1% | |
SAREPTA THERAPEUTICS INC | -3.0% | |
PTC THERAPEUTICS INC | -2.9% | |
VERACYTE INC | -2.9% | |
CATALYST PHARMACEUTICAL PART | -2.7% |